insights_auto
Why is EBS up 3.67%?
Dive Deeperchevron_right
EBS:NYSE
Emergent Biosolutions Inc
$ 7.06
arrow_upward
+3.67%(+0.25) 1D
$ 7.01
arrow_downward
-0.71% (-0.050)bedtimeAfter hours
Closed: 10-р сарын 9, 16:00:07 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EBS...
Open
$ 6.73
High
$ 7.06
Low
$ 6.60
Mkt. cap
361.99 сая
Avg. vol.
1.18 сая
Volume
850.96 мян
52-wk high
$ 14.06
52-wk low
$ 4.36
EPS
-$ 3.51
Beta
2.28
Shares outstanding
51.27 сая
No. of employees
900
Open
$ 6.73
High
$ 7.06
Low
$ 6.60
Mkt. cap
361.99 сая
Avg. vol.
1.18 сая
Volume
850.96 мян
52-wk high
$ 14.06
52-wk low
$ 4.36
EPS
-$ 3.51
Beta
2.28
Shares outstanding
51.27 сая
No. of employees
900
News stories
From web sources and news partners
Bloomberg.com
·
25 минутын өмнө
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap
Yahoo Finance
·
3 цагийн өмнө
Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor
Seeking Alpha
·
2 цагийн өмнө
S&P 500: The Quick And Easy Days Are Over (SP500)
The Motley Fool
·
4 цагийн өмнө
The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus
Profile
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
About Emergent Biosolutions Inc
CEORobert G. Kramer Sr. | Joseph C. Papa
Employees900
Founded1998 оны 9-р сарын 5
HeadquartersRockville, Мэрилэнд, Америкийн Нэгдсэн Улс
Sector-
Websiteemergentbiosolutions.com